76 related articles for article (PubMed ID: 3791396)
1. Update on haematologic malignancy.
Jacobs P
Cent Afr J Med; 1986 Apr; 32(4):100-6. PubMed ID: 3791396
[No Abstract] [Full Text] [Related]
2. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
3. [Aspects of molecular remission in hematology and oncology].
Novik AA; Kamilova TA; Tsygan VN
Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823
[No Abstract] [Full Text] [Related]
4. [Bone marrow transplantation--rapid development towards new indications].
Gahrton G; Ringdén O; Robert KH
Lakartidningen; 1988 Mar; 85(9):689-91, 695. PubMed ID: 3280928
[No Abstract] [Full Text] [Related]
5. [Interferons in cancerology. Focus in 1988].
Boiron M
Pathol Biol (Paris); 1989 Feb; 37(2):92-3. PubMed ID: 2652080
[No Abstract] [Full Text] [Related]
6. [Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].
Bernasconi C
Haematologica; 1990; 75 Suppl 4():82-4. PubMed ID: 2074058
[No Abstract] [Full Text] [Related]
7. Interferon in the treatment of multiple myeloma and non Hodgkins lymphoma.
Smruti BK; Nair R; Gopal R
J Assoc Physicians India; 1995; Suppl 3():33-7. PubMed ID: 8773120
[No Abstract] [Full Text] [Related]
8. New developments in peripheral blood stem cell transplants.
Hénon P
Leukemia; 1992 Nov; 6 Suppl 4():106-9. PubMed ID: 1359201
[No Abstract] [Full Text] [Related]
9. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Gola A
Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic transplant of CD34+ peripheral blood cells from HLA-identical donors: Spanish experience of 40 cases. Allo-Peripheral Blood Transplantation Group].
Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteyza J; Sierra J; García-Conde J; Rozman C
Sangre (Barc); 1997 Apr; 42 Suppl 1():44-5. PubMed ID: 9381302
[No Abstract] [Full Text] [Related]
11. The treatment of the reticuloses.
Matthias JQ
Practitioner; 1966 Jan; 196(171):96-103. PubMed ID: 5323012
[No Abstract] [Full Text] [Related]
12. [Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group].
Brunet S; Urbano-Ispizua A; Solano C; Ojeda E; Caballero D; Torrabadella M; de la Rubia J; Pérez-Oteiza J; Moraleda J; Espigado I; de la Serna J; Petit J; Bargay J; Mataix R; Vivancos P; Figuera A; Sierra J; Domingo-Albós A; Hernández F; García Conde J; Rozman C
Sangre (Barc); 1997 Apr; 42 Suppl 1():42-3. PubMed ID: 9381301
[No Abstract] [Full Text] [Related]
13. Peripheral blood progenitor cell transplantation for hematological malignancies.
Reiffers J
Immunomethods; 1994 Dec; 5(3):211-6. PubMed ID: 7780688
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of combining ATRA with G-CSF in HSPC mobilization; a pilot study in multiple myeloma and non-Hodgkin's lymphoma patients.
Herbert KE; True S; McArthur G; Prince HM
Bone Marrow Transplant; 2007 Oct; 40(8):801-3. PubMed ID: 17680017
[No Abstract] [Full Text] [Related]
16. [Our experience in the use of the hemosorption method in the combined therapy of patients with several forms of hemoblastoses].
Nakhimov EI; Lebedev VN; Mochanov AS
Gematol Transfuziol; 1983 Nov; 28(11):56-8. PubMed ID: 6689159
[No Abstract] [Full Text] [Related]
17. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
18. DLI or second transplant.
Greinix HT
Ann Hematol; 2002; 81 Suppl 2():S34-5. PubMed ID: 12611068
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of malignant hematological diseases].
SANCHEZ MEDAL L
Gac Med Mex; 1953; 83(6):443-51. PubMed ID: 13151339
[No Abstract] [Full Text] [Related]
20. Intensive therapy for medical complications of haematological malignancy at the Royal Marsden Hospital.
Banerjee A; Lakhani S; McElwain TJ; Powles R
Intensive Care Med; 1987; 13(3):213-4. PubMed ID: 3584651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
